Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 17
Doktorska disertacija
Oznake: revmatologija;registri;BioRx.si;Bolezni gibal;Disertacije;Revmatoidni artritis;Zdravljenje;Farmacija;Biološka zdravila;Učinkovitost;Varnost;
Cilj Prikaz uporabnosti podatkov iz registra BioRx.si za spremljanje učinkovitosti (hipotezi 1A in 1B) in varnosti (hipoteza 2) bioloških zdravil (bDMARD), ki jih uporabljamo za zdravljenje revmatskih bolezni. Hipoteze 1A. Pri bolnikih z revmatoidnim artritisom (RA), pri katerih je prvi zaviralec d ...
Leto: 2020 Vir: Medicinska fakulteta (UL MF)
Izvirni znanstveni članek
Oznake: epidemiology;rheumatology;tuberculosis;
Objectives: This study aimed to assess the risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) treated with any of the commercially available tumour necrosis factor inhibitors (TNFis) in Slovenia. Design: This is a cohort, r ...
Leto: 2020 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Izvirni znanstveni članek
Oznake: thrombosis;antiphospholipid syndrome;antiphospholipid antibodies;
Antiphospholipid syndrome (APS) is an important cause of deep vein thrombosis (DVT). According to current APS classification criteria, APS cannot be confirmed until 24 weeks after DVT. This time frame results in frequent discontinuation of anticoagulant treatment before APS is diagnosed. Therefore, ...
Leto: 2021 Vir: Medicinska fakulteta (UL MF)
Izvirni znanstveni članek
Oznake: anti-β2GPI;anticardiolipin;antiphospholipid syndrome;classification criteria;
Objectives: Recently published 2023 ACR/EULAR APS classification criteria emphasize the importance of quantifying single-, double-, and triple-antiphospholipid antibody positivity, distinguishing between IgG and IgM isotypes, and delineating moderate/high levels of anticardiolipin (aCL) and anti-β2 ...
Leto: 2025 Vir: Repozitorij Univerze v Ljubljani (RUL)
Izvirni znanstveni članek
Oznake: disease activity states;ankylosing spondylitis;axial spondyloarthritis;multinational European cohort;
Objective: The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is widely used for assessing disease activity in patients with axial spondyloarthritis (axSpA), particularly in settings where markers of inflammation are unavailable. As no consensus on BASDAI cut-off values exists for disea ...
Leto: 2025 Vir: Medicinska fakulteta (UL MF)
Izvirni znanstveni članek
Oznake: velikanski celični arteritis;mikroRNA;preoblikovanje arterij;giant cell arteritis;microRNA;arterial remodelling;
In this study, we explored expression of microRNA (miR), miR-target genes and matrix remodelling molecules in temporal artery biopsies (TABs) from treatment-naïve patients with giant cell arteritis (GCA, n = 41) and integrated these analyses with clinical, laboratory, ultrasound and histological man ...
Leto: 2021 Vir: Medicinska fakulteta (UL MF)
Izvirni znanstveni članek
Oznake: adverse cardiovascular events;rheumatoid arthritis;patients;Janus kinase inhibitors;biologic disease-modifying antirheumatic drugs;"JAK-pot" study;
Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs
Leto: 2025 Vir: Repozitorij Univerze v Ljubljani (RUL)
Izvirni znanstveni članek
Oznake: axial psoriatic arthritis;axial spondyloarthritis;imaging;magnetic resonance imaging;
Background: Axial involvement in psoriatic arthritis (axPsA) is associated with more severe disease and increased pain, yet no consensus definition of axPsA exists. This study aims to describe the occurrence and characteristics of MRI and radiographic sacroiliac joint (SIJ) involvement in a European ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Izvirni znanstveni članek
Oznake: TNF inhibitors;joint;psoriatic arthritis;
Background: Efficacy of tumour necrosis factor inhibitors (TNFi) for peripheral arthritis in patients with psoriatic arthritis (PsA) has been established in randomized clinical trials that have used improvement in summated joint counts as an outcome. Whether joints at different anatomical locations ...
Leto: 2025 Vir: Repozitorij Univerze v Ljubljani (RUL)
Pregledni znanstveni članek
Oznake: access to health care;axial spondyloarthritis;biologic therapy;health policy;psoriatic arthritis;socioeconomic health disparties;
Background: Studies on national policies for biologics are warranted. Objectives: To map and compare national healthcare set-ups for prescription, start, switch, tapering, and discontinuation of biologic/targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in patients with psoriatic art ...
Leto: 2025 Vir: Repozitorij Univerze v Ljubljani (RUL)
Št. zadetkov: 17
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: